Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

SHE:000623 Revenue

Jilin Aodong Pharmaceutical Group had revenue of 514.09M CNY in the quarter ending March 31, 2026, a decrease of -17.43%. This brings the company's revenue in the last twelve months to 2.23B, down -6.12% year-over-year. In the year 2025, Jilin Aodong Pharmaceutical Group had annual revenue of 2.34B, down -10.55%.

• Revenue (ttm): 2.23B
• Revenue Growth: -6.12%
• P/S Ratio: 9.40
• Revenue / Employee: 407.74K
• Employees: 5,461
• Market Cap: 20.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.34B	-275.38M	-10.55%
Dec 31, 2024	2.61B	-838.55M	-24.31%
Dec 31, 2023	3.45B	580.91M	20.25%
Jan 1, 2023	2.87B	564.45M	24.50%
Jan 1, 2022	2.30B	52.11M	2.31%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 19, 2026

Data Sources Report a data error